Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting.

ICIs and MAPKis were effective in this real-world population, and we could confirm the importance of previously reported clinical prognostic markers. Albumin values may be associated with therapy outcome but need further validation.